France
· Delayed Price · Currency is EUR ABIVAX Société Anonyme Statistics
Total Valuation
ABIVAX Société Anonyme has a market cap or net worth of EUR 723.76 million. The enterprise value is 537.23 million.
| Market Cap | 723.76M |
| Enterprise Value | 537.23M |
Important Dates
The next estimated earnings date is Monday, September 9, 2024.
| Earnings Date | Sep 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABIVAX Société Anonyme has 63.27 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 63.27M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 30.06% |
| Float | 26.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 109.65 |
| PB Ratio | 3.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.64 |
| EV / Sales | 119.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.52 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 37.99.
| Current Ratio | 4.08 |
| Quick Ratio | 4.00 |
| Debt / Equity | 37.99 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.76 |
| Interest Coverage | -9.22 |
Financial Efficiency
Return on equity (ROE) is -145.41% and return on invested capital (ROIC) is -48.74%.
| Return on Equity (ROE) | -145.41% |
| Return on Assets (ROA) | -39.57% |
| Return on Capital (ROIC) | -48.74% |
| Revenue Per Employee | 73,656 |
| Profits Per Employee | -2.42M |
| Employee Count | 61 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.72% in the last 52 weeks. The beta is 1.46, so ABIVAX Société Anonyme's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -33.72% |
| 50-Day Moving Average | 11.41 |
| 200-Day Moving Average | 11.86 |
| Relative Strength Index (RSI) | 62.32 |
| Average Volume (20 Days) | 24,822 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ABIVAX Société Anonyme had revenue of EUR 4.49 million and -147.74 million in losses. Loss per share was -3.43.
| Revenue | 4.49M |
| Gross Profit | 4.49M |
| Operating Income | -127.46M |
| Pretax Income | -147.74M |
| Net Income | -147.74M |
| EBITDA | -127.25M |
| EBIT | -127.46M |
| Loss Per Share | -3.43 |
Balance Sheet
The company has 260.99 million in cash and 74.47 million in debt, giving a net cash position of 186.53 million or 2.95 per share.
| Cash & Cash Equivalents | 260.99M |
| Total Debt | 74.47M |
| Net Cash | 186.53M |
| Net Cash Per Share | 2.95 |
| Equity (Book Value) | 196.01M |
| Book Value Per Share | 3.12 |
| Working Capital | 215.93M |
Cash Flow
In the last 12 months, operating cash flow was -97.13 million and capital expenditures -265,000, giving a free cash flow of -97.40 million.
| Operating Cash Flow | -97.13M |
| Capital Expenditures | -265,000 |
| Free Cash Flow | -97.40M |
| FCF Per Share | -1.54 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,836.79% |
| Pretax Margin | -3,288.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,167.71% |
Dividends & Yields
ABIVAX Société Anonyme does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -29.99% |
| FCF Yield | -13.46% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |